Home
/
HERBALIFE LTD.
/
Financials
/
Quarterly
HERBALIFE LTD. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HERBALIFE LTD. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.27B
Nov 5, 2025
Q2
2025
Jun 30, 2025
$1.26B
Aug 6, 2025
Q1
2025
Mar 31, 2025
$1.22B
Apr 30, 2025
Q3
2025
Sep 30, 2024
$1.24B
Nov 5, 2025
Q2
2025
Jun 30, 2024
$1.28B
Aug 6, 2025
Q1
2025
Mar 31, 2024
$1.26B
Apr 30, 2025
Q3
2024
Sep 30, 2023
$1.28B
Oct 30, 2024
Q2
2024
Jun 30, 2023
$1.31B
Jul 31, 2024
Q1
2024
Mar 31, 2023
$1.25B
May 1, 2024
Q3
2023
Sep 30, 2022
$1.30B
Nov 1, 2023
Q2
2023
Jun 30, 2022
$1.39B
Aug 2, 2023
Q1
2023
Mar 31, 2022
$1.34B
May 2, 2023
Q3
2022
Sep 30, 2021
$1.43B
Oct 31, 2022
Q2
2022
Jun 30, 2021
$1.55B
Aug 2, 2022
Q1
2022
Mar 31, 2021
$1.50B
May 3, 2022
Q3
2021
Sep 30, 2020
$1.52B
Nov 2, 2021
Q2
2021
Jun 30, 2020
$1.35B
Aug 3, 2021
Q1
2021
Mar 31, 2020
$1.26B
May 4, 2021
Q3
2020
Sep 30, 2019
$1.24B
Nov 5, 2020
Q2
2020
Jun 30, 2019
$1.24B
Aug 6, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$1.29B
Aug 1, 2018
Q1
2018
Mar 31, 2018
$1.18B
May 3, 2018
Q3
2017
Sep 30, 2017
$1.09B
Nov 2, 2017
Q2
2018
Jun 30, 2017
$1.15B
Aug 1, 2018
Q1
2018
Mar 31, 2017
$1.10B
May 3, 2018
Q3
2017
Sep 30, 2016
$1.12B
Nov 2, 2017
Q2
2017
Jun 30, 2016
$1.20B
Aug 1, 2017
Q1
2017
Mar 31, 2016
$1.12B
May 4, 2017
Q3
2016
Sep 30, 2015
$1.10B
Nov 1, 2016
Q2
2016
Jun 30, 2015
$1.16B
Aug 3, 2016
Q1
2016
Mar 31, 2015
$1.11B
May 5, 2016
Q3
2015
Sep 30, 2014
$1.26B
Nov 3, 2015
Q2
2015
Jun 30, 2014
$1.31B
Aug 5, 2015
Q1
2015
Mar 31, 2014
$1.26B
May 5, 2015
Q3
2014
Sep 30, 2013
$1.21B
Nov 3, 2014
Q2
2014
Jun 30, 2013
$1.22B
Jul 28, 2014
Q1
2014
Mar 31, 2013
$1.12B
Apr 28, 2014
Q3
2013
Sep 30, 2012
$1.02B
Dec 16, 2013
Q2
2013
Jun 30, 2012
$1.03B
Dec 16, 2013
Q1
2013
Mar 31, 2012
$964.18M
Dec 16, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$43.20M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$49.30M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$50.40M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$47.40M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$4.70M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$24.30M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$42.80M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$59.90M
Jul 31, 2024
Q1
2024
Mar 31, 2023
$29.30M
May 1, 2024
Q3
2023
Sep 30, 2022
$82.20M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$86.50M
Aug 2, 2023
Q1
2023
Mar 31, 2022
$98.20M
May 2, 2023
Q3
2022
Sep 30, 2021
$117.40M
Oct 31, 2022
Q2
2022
Jun 30, 2021
$144.20M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$147.40M
May 3, 2022
Q3
2021
Sep 30, 2020
$138.10M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$115.10M
Aug 3, 2021
Q1
2021
Mar 31, 2020
$45.60M
May 4, 2021
Q3
2020
Sep 30, 2019
$81.50M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$76.50M
Aug 6, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$125.80M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$132.60M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$122.80M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$127.10M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$80.40M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$71.90M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$106.70M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$123.40M
Jul 31, 2024
Q1
2024
Mar 31, 2023
$70.50M
May 1, 2024
Q3
2023
Sep 30, 2022
$147.40M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$155.80M
Aug 2, 2023
Q1
2023
Mar 31, 2022
$153.10M
May 2, 2023
Q3
2022
Sep 30, 2021
$189.40M
Oct 31, 2022
Q2
2022
Jun 30, 2021
$237.90M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$222.50M
May 3, 2022
Q3
2021
Sep 30, 2020
$206.90M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$189.70M
Aug 3, 2021
Q1
2021
Mar 31, 2020
$95.60M
May 4, 2021
Q3
2020
Sep 30, 2019
$143.60M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$153.10M
Aug 6, 2020